Association of Serum 25-hydroxyvitamin D3, Fibroblast Growth Factor-23, and C1q/tumor Necrosis Factor-related Protein-3 with Coronary Artery Calcification in Nondialysis Chronic Kidney Disease Patients

Overview

Journal Ren Fail

Publisher Informa Healthcare

Date 2023 Jun 9

PMID 37293793

Authors

Yuanjie Zhu

Zhijuan Hu

Yu Liu

Congcong Qin

Xing Chen

Yanan Shi

Lijun Wang

Affiliations

Soon will be listed here.

Abstract

Objective: To assess serum 25-hydroxyvitamin D3 (25(OH)D3), fibroblast growth factor 23 (FGF23), and C1q/tumor necrosis factor-related protein-3 (CTRP3) levels in nondialysis chronic kidney disease (CKD) patients and their relationship with coronary artery calcification (CAC).

Methods: One hundred and twenty-eight patients diagnosed with CKD were selected and all underwent cardiac computed tomography. CAC was assessed using the Agatston score, and coronary artery calcification score (CACs) >10 was identified as CAC. The differences in serum 25(OH)D3, FGF23, and CTRP3 levels between the CAC and non-CAC groups were analyzed. Their correlation with CACs was assessed by Spearman's analysis, and logistic regression analysis was used to find risk factors for CAC.

Results: Compared to the non-CAC group, the CAC group was older (64.21 ± 9.68 years), with a higher percentage of hypertension (93.10%) and diabetes (63.80%) and higher levels of serum CTRP3 [1079.20 (644.4-1567.2) ng/mL]. However, there was no significant difference in serum 25(OH)D3 and FGF23 between these two groups. The high level CTRP3 group had a higher prevalence of CAC (61.5%). Logistic regression results showed that age, diabetes, decreased 25(OH)D3 (odds ratio (OR) = 0.95, = .030) and high levels of CTRP3 (OR = 3.19, = .022) were risk factors for CAC in nondialysis CKD patients.

Conclusions: Serum CTRP3 levels progressively increased with the progression of kidney disease, while 25(OH)D3 levels progressively decreased. Decreased 25(OH)D3 and high levels of CTRP3 are associated with CAC in patients with nondialysis CKD.

Citing Articles

Exploring the mediating role of calcium homeostasis in the association between diabetes mellitus, glycemic traits, and vascular and valvular calcifications: a comprehensive Mendelian randomization analysis.

Zhu X, Liu G, Peng Y, Zhang L, Wang X, Chen L Diabetol Metab Syndr. 2024; 16(1):136.

PMID: 38907296 PMC: 11193216. DOI: 10.1186/s13098-024-01383-z.

Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies.

Kencono Wungu C, Susilo H, Alsagaff M, Witarto B, Witarto A, Pakpahan C Sci Rep. 2024; 14(1):5712.

PMID: 38459119 PMC: 10923819. DOI: 10.1038/s41598-024-56377-8.

References

Moradi N, Fadaei R, Khamseh M, Nobakht A, Rezaei M, Aliakbary F . Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function. PLoS One. 2019; 14(4):e0215617. PMC: 6476508. DOI: 10.1371/journal.pone.0215617. View

Garcia-Canton C, Bosch E, Ramirez A, Gonzalez Y, Auyanet I, Guerra R . Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2010; 26(7):2250-6. DOI: 10.1093/ndt/gfq650. View

Srivaths P, Goldstein S, Silverstein D, Krishnamurthy R, Brewer E . Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol. 2011; 26(6):945-51. DOI: 10.1007/s00467-011-1822-0. View

Rumberger J, Brundage B, Rader D, Kondos G . Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999; 74(3):243-52. DOI: 10.4065/74.3.243. View

Scialla J, Lau W, Reilly M, Isakova T, Yang H, Crouthamel M . Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int. 2013; 83(6):1159-68. PMC: 3672330. DOI: 10.1038/ki.2013.3. View

. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020; 395(10225):709-733. PMC: 7049905. DOI: 10.1016/S0140-6736(20)30045-3. View

Yun H, Joo Y, Kim H, Park J, Chang T, Son N . Coronary Artery Calcification Score and the Progression of Chronic Kidney Disease. J Am Soc Nephrol. 2022; 33(8):1590-1601. PMC: 9342644. DOI: 10.1681/ASN.2022010080. View

Wang X, Zhang J, Xu X, Wu Y . Prevalence of coronary artery calcification and its association with mortality, cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2019; 41(1):244-256. PMC: 6493287. DOI: 10.1080/0886022X.2019.1595646. View

Jimbo R, Kawakami-Mori F, Mu S, Hirohama D, Majtan B, Shimizu Y . Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency. Kidney Int. 2013; 85(5):1103-11. DOI: 10.1038/ki.2013.332. View

10.

Goluke N, Schoffelmeer M, de Jonghe A, Emmelot-Vonk M, de Jong P, Koek H . Serum biomarkers for arterial calcification in humans: A systematic review. Bone Rep. 2022; 17:101599. PMC: 9234354. DOI: 10.1016/j.bonr.2022.101599. View

11.

Matsushita K, Ballew S, Yee-Moon Wang A, Kalyesubula R, Schaeffner E, Agarwal R . Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022; 18(11):696-707. DOI: 10.1038/s41581-022-00616-6. View

12.

Wang S, Ling Y, Liang W, Shen L . Association of serum C1q/TNF-related protein-3 (CTRP-3) in patients with coronary artery disease. BMC Cardiovasc Disord. 2017; 17(1):210. PMC: 5534082. DOI: 10.1186/s12872-017-0646-7. View

13.

Choi K, Hwang S, Hong H, Yang S, Choi H, Yoo H . C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome. Diabetes. 2012; 61(11):2932-6. PMC: 3478553. DOI: 10.2337/db12-0217. View

14.

Inker L, Eneanya N, Coresh J, Tighiouart H, Wang D, Sang Y . New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021; 385(19):1737-1749. PMC: 8822996. DOI: 10.1056/NEJMoa2102953. View

15.

Maghbooli Z, Hossein-Nezhad A, Khoshechin G, Niketeghad G, Moradi S, Adabi E . Possible association between circulating CTRP3 and knee osteoarthritis in postmenopausal women. Aging Clin Exp Res. 2018; 31(7):927-934. DOI: 10.1007/s40520-018-1035-5. View

16.

Gregg L, Hedayati S . Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?. Am J Kidney Dis. 2018; 72(5):728-744. PMC: 6107444. DOI: 10.1053/j.ajkd.2017.12.007. View

17.

Ozkok A, Kekik C, Karahan G, Sakaci T, Ozel A, Unsal A . FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. BMC Nephrol. 2013; 14:241. PMC: 3830511. DOI: 10.1186/1471-2369-14-241. View

18.

Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke H, Choukroun G . FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int. 2011; 23(7):2017-25. DOI: 10.1007/s00198-011-1838-0. View

19.

Agatston A, Janowitz W, HILDNER F, Zusmer N, VIAMONTE Jr M, Detrano R . Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15(4):827-32. DOI: 10.1016/0735-1097(90)90282-t. View

20.

Pillar R, G Lopes M, Rocha L, Cuppari L, Carvalho A, Draibe S . Severe hypovitaminosis D in chronic kidney disease: association with blood pressure and coronary artery calcification. Hypertens Res. 2013; 36(5):428-32. DOI: 10.1038/hr.2012.230. View